Filters
Hikma announces exclusive licensing and supply agreement with Hansoh Pharma for suite of injectable oncology medicines
Press Release, Product
Hikma announces global agreement with Vectura to develop generic versions of GSK’s Ellipta® portfolio
Press Release, Corporate
Hikma updates on current trading and raises 2018 guidance
Press Release, Corporate
REMINDER Investor Day 8 November 2018, 12.30pm for 1.30pm
Press Release, Corporate
Hikma launches Imatinib Mesylate Tablets
Press Release, Product
Hikma Receives Recognition for Supporting United Nations Sustainable Development Goals
Press Release, Responsibility
Hikma Ventures participates in a $19 million round for Click Therapeutics
Press Release, Corporate
Hikma Appoints Global Head of Intellectual Property and US General Counsel
Press Release, Corporate
Hikma launches AdriamycinTM (DOXOrubicin HCl) for Injection, USP
Press Release, Product
Hikma Remains Constituent of FTSE4Good Index Series
Press Release, Responsibility
Hikma Pharmaceuticals appoints Kristy Ronco Executive Vice President, Sales and Marketing, Generics
Press Release, Corporate
Hikma reports strong 2018 interim results and raises full year guidance
Press Release, Corporate
Hikma launches Sterile Water for Injection, USP
Press Release, Product